Porcine milk small extracellular vesicles modulate peripheral blood mononuclear cell proteome in vitro

doi:10.21203/rs.3.rs-4953340/v1

Download PDF

Article

Porcine milk small extracellular vesicles modulate peripheral blood mononuclear cell proteome in vitro

https://doi.org/10.21203/rs.3.rs-4953340/v1

This work is licensed under a CC BY 4.0 License

You are reading this latest preprint version

Small extracellular vesicles (EVs) are a subtype of nano-sized extracellular vesicles that mediate intercellular communication. EVs can be found in different body fluids, including milk. Monocytes internalize porcine milk EVs and modulate immune functions in vitro by decreasing their phagocytosis and chemotaxis while increasing their oxidative burst This study aimed to assess the impact of porcine milk EVs on the porcine peripheral blood mononuclear cells (PBMC) proteome.

Porcine PBMC were incubated with porcine milk EVs or medium as a control. Extracted proteins were then analyzed using nano-LC-MS/MS. A total of 1584 proteins were identified. The supervised multivariate statistical analysis, sparse variant partial least squares – discriminant analysis (sPLS-DA) for paired data identified discriminant proteins (DP) that contributed to a clear separation between the porcine milk EV treated cells and control groups. A total of 384 DP from both components were selected. Gene Ontology (GO) enrichment analysis with ProteINSIDE provided the evidence that the DP with a higher abundance in porcine milk EVs, like TLR2, APOE, CD36, MFGE8, were mainly involved in innate immunity and EV uptake processes. These results provide a proteomics background to the immunomodulatory activity of porcine milk EVs and to the potential mechanisms used by immune cells to internalize them.

Biological sciences/Systems biology

Biological sciences/Biological techniques/Proteomic analysis

milk small extracellular vesicles

pig

PBMC

immunomodulation

phagocytosis

proteomics

Small extracellular vesicles (EVs) are nano-sized extracellular vesicles (30–160 nm) with an endosome-derived limiting membrane mediating intercellular communication in physiological and pathological conditions ^1,2. They can be produced and released by all cell types through exocytosis ³. EVs carry a wide range of regulatory molecules (cargo) such as proteins, lipids, DNA, RNA (mRNA, miRNA, non-coding RNA), and metabolites ¹. These nanovesicles mediate near long-distance intercellular communication by targeting and transferring their cargo into recipient cells, altering their function ^4,5.

Over the last two decades, EVs have been demonstrated to induce, amplify, and suppress innate and adaptive immune responses. Indeed, EVs have been shown to modulate natural killer (NK) cell activation, macrophage and T cell differentiation, and monocyte chemotaxis ^6–8. Anti-inflammatory roles of EVs in human peripheral blood mononuclear cells (PBMC) and T cells have also been reported ⁹.

EVs can be found in different body fluids, including milk ¹⁰. Milk EVs are also thought to exert potential immunomodulatory effects, as human and bovine milk EVs containing functional RNA are taken up by human macrophages ^11,12. After suckling or oral administration, bovine, porcine, or murine milk EVs and their cargo can accumulate in piglets and mice peripheral tissues, like the liver, spleen, lung, and small intestine, that are rich in immune cells ¹³, suggesting potential immunomodulation. Moreover, our previous in vitro study demonstrated that porcine milk EVs exert immunomodulatory effects on porcine monocytes by decreasing their phagocytosis and chemotaxis and increasing their reactive oxygen species (ROS) production ¹⁴. However, the molecular mechanisms underlying the immunomodulatory activity of porcine milk EVs on porcine mononuclear cells are still unknown.

OMIC technologies, specifically proteomics – the large-scale study of the protein profile in a sample – provide a great option to unravel the molecular impact of porcine milk EVs on porcine PBMC immune response ¹⁵. In previous studies, porcine PBMC proteome has been investigated, mainly in the context of infectious diseases ¹⁶, stress ¹⁷, pregnancy ¹⁸, and characterization of the cell's protein profile ¹⁹. Still, there is no information on the in vitro impact of milk EVs on porcine PBMC proteome. Therefore, this study covers this gap by describing for the first time the immunomodulatory capacity of porcine milk EVs on porcine PBMC proteome in vitro, using an untargeted proteomics approach.

The proteome of porcine PBMC and identification of the molecular signature of porcine milk EVs treatment

A total of 1584 proteins, with at least two unique peptides, were identified and quantified in porcine PBMC (Supplementary Table S1). A multivariate sPLS-DA analysis was applied to determine the molecular signature of the porcine milk EVs treatment. The sPLS-DA model selected a total of 384 DP (approximately 25% of the total proteins identified) from both components (Supplementary Table S2), providing a good clustering between the two treatment groups (Fig. 1).

From the 384 DP, only the proteins from the sPLS-DA component 1 that strongly correlated together for each treatment group were selected to perform separate GO BP enrichment analyses. Of these proteins, 54 had the highest abundance in the milk EVs group, while 142 were in the control group (Supplementary Table S3).

GO enrichment analyses of total DP identified by s-PLS-DA.

A GO enrichment analysis was performed to identify the global function of all 384 DP. These DP were annotated by 301 enriched (FDR < 0.05) GO terms within the BP category. The main enriched BP were related to cellular supramolecular fiber organization (GO:0097435), metabolic process (GO:0008152), actin cytoskeleton organization (GO:0030036), intracellular transport (GO:0046907), positive regulation of organelle organization (GO:0010638), translation (GO:0006412), regulation of vesicle-mediated transport (GO:0060627), gene expression (GO:0010467), immune system process (GO:0002376) and regulation of apoptotic signaling pathway (GO:2001233) (Fig. 2).

Among the most annotated BP were: gene expression (142), metabolic processes (92), immune system process (70) and intracellular transport (50) (Supplementary Table S4).

GO enrichment analyses of DP with the highest abundance in the milk EVs group.

To further elucidate the specific role of the DP with the highest abundance in each group, separate GO enrichment analyses were performed. The 54 proteins with the highest abundance in the milk EVs group were annotated by 130 enriched (FDR < 0.05) GO terms within the BP category. These proteins were mainly involved in BP such as cellular detoxification (GO:1990748), response to diacyl bacterial lipopeptide (GO:0071726), nitric oxide-mediated signal transduction (GO:0007263), cGMP-mediated signaling (GO:0019934), positive regulation of tumor necrosis factor production (GO:0032760), positive regulation of endocytosis (GO:0045807), secretion (GO:0071706), immune system process (GO:0002376), ERK1 and ERK2 cascade (GO:0070371), regulation of body fluid levels (GO:0050878) and phagocytosis, recognition (GO:0006910). From these enriched BP, the ones with the highest number of annotated proteins were the immune system process with nine proteins, secretion with six proteins, and ERK1 and ERK2 cascade and regulation of body fluid with five proteins (Fig. 3).

CD36 and APOE were mainly annotated by almost all of these enriched BP. SASH3, CLU, and Cathepsin H (CTSH) were found in the immune system process, but CLU and CTSH were also found in positive regulation of endocytosis and ERK1 and ERK2 cascade, respectively. Moreover, TLR2 was found in the biological processes involved with the response to bacterial lipopeptide, immune system process, and secretion. In the latter and the regulation of body fluids, CSN2 and CSN3 were also found. Lastly, MFGE8 was only found in phagocytosis (Supplementary Table S5).

GO enrichment analyses of DP with the highest abundance in the control group.

A higher number of DP (142) was found to be more abundant in the control group. These proteins were annotated by 64 enriched (FDR < 0.05) BP GO terms. These enriched GO terms were mainly related to the catabolic process (GO:0009056), amide biosynthetic process (GO:0043604), cellular organization (GO:0051641), translation (GO:0006412), metabolic process (GO:0008152), vesicle budding from the membrane (GO:0006900), vesicle-mediated transport (GO:0016192), regulation of anoikis (GO:2000209) and interleukin-27-mediated signaling pathway (GO:0070106) (Fig. 4).

The enriched BP with the highest number of annotated proteins were: metabolic processes (87), cellular localization (35) and catabolic process (34) (Supplementary Table S6).

Average log fold-change (logFC) of the abundances of the DP identified with sPLS-DA

Lastly, to identify and focus on key DP that presented greater changes in their abundance after porcine milk EVs treatment, the average logFC of the raw abundances of the proteins from the cells treated with milk EVs was calculated (Fig. 5).

The protein with the most significant change in the abundance (logFC > 100) between the milk EVs and control was CSN2. Other proteins with higher abundances in the milk EVs group were found, including BTN1A1, CSN1S1, CSN1S2, MFGE8, and SLC34A2 (logFC > 5). On the other hand, FABP4 (logFC < 0.5) and LGALS3 (logFC < 1) showed the lowest abundance in the milk EVs group.

The present study describes the proteome of porcine PBMC after stimulation with milk EVs, demonstrating that milk EVs co-incubation enriches biological processes (BP) involved in phagocytosis, endocytosis, and, more generally, inflammatory response, and immune reaction. These findings support, at the proteomics level, our recent findings that EVs have an immunomodulatory activity on porcine monocytes ¹⁴.

Global biological processes enriched by the DP selected by sPLS-DA

The sPLS-DA model selected the most discriminant proteins (DP), allowing an evident clustering of the samples between the EVs-treated PBMC and the control groups ²⁰. Consistently with the immunomodulatory activity on PBMC previously observed, the GO enrichment analysis revealed that EVs activate BP-like actin cytoskeleton organization and cellular supramolecular fiber organization, intracellular transport, positive organelle organization regulation, vesicle-mediated transport, all of them involved in chemotaxis-related processes and both BP associated with chemotaxis, phagocytosis, and cell communication ^21–25.

Biological processes enriched by DP with the highest abundance in the EVs-treated PBMC toward changes in phagocytosis and inflammatory response

Separate GO enrichment analyses were performed using the DP with the highest abundance in each group to elucidate further the differences between the two groups. The 54 DP with the highest abundance in the porcine milk EVs group enriched BP in the immune system process, including phagocytosis, positive regulation of tumor necrosis factor production response to diacyl bacterial lipopeptide, and nitric oxide-mediated signal transduction.

Phagocytosis plays an essential role in the uptake of EVs by monocytes and macrophages ^26,27. Several proteins involved in phagocytosis were found as highly abundant in the EVs -treated PBMC, namely glycoprotein IIIb (CD36), milk fat globule-EGF factor 8 (MFGE8 – lactadherin), extracellular signal-regulated kinase 1/2 (ERK1/2), and apolipoprotein E (APOE).

CD36 is one of the proteins involved in almost all enriched BP. CD36 is a PBMC membrane glycoprotein that participates in the identification and phagocytosis of apoptotic cells, ROS production, and macrophage modulation ^28–30. The fact that CD36 is related to phagocytosis and endocytosis, the main mechanisms of EV internalization, explains the uptake of porcine milk EVs by porcine monocytes, previously demonstrated by our team ¹⁴.

The milk fat globule-EGF factor 8 (MFGE8 – lactadherin) is a phosphatidylserine-binding glycoprotein secreted and expressed by macrophages that promotes the engulfment of apoptotic cells and vesicles ^31,32. It is also one of the immune components found in milk, specifically in milk fat globules, and highly enriched in milk EVs ^33,34. MFGE8 may also play a role in the intestinal immune system of newborns [35] and is involved in EV phagocytosis by macrophages and monocytes ³⁶. The extracellular signal-regulated kinase 1/2 (ERK1/2) cascade signaling pathway regulates several stimulated cellular processes, including, among others, migration, apoptosis, and stress response ³⁷. A previous study showed that EVs activated the ERK1/2 cascade and that its activity is necessary for efficient EV uptake via lipid raft-mediated endocytosis ³⁸. It was previously found that EVs and their miRNA cargo can modulate the ERK1/2 signaling pathway to induce immunomodulatory effects such as reducing macrophage migration ³⁹. Finally, APOE - a major protein component of very-low and high-density lipoproteins mainly expressed by monocytes/macrophages- has been shown to exert anti-inflammatory roles, including reducing the migration of some cells ^40,41. Our results are consistent with previous reports, demonstrating that EVs released by anti-inflammatory (M2) macrophages increase the levels of APOE in the cancer cells and modulate their migratory capacity through the transfer of functional APOE ⁴². The presence of APOE in porcine colostrum and milk EVs has already been reported ⁴³. The function of APOE in modulating the migration of different cell types seems to be mediated in a MAPK/ERK1/2, explaining why this DP was also found annotated in the ERK1/2 cascade BP ⁴⁴.

Some significant DP are also involved in modulating inflammatory response, like TLR2. Our results agree with previous studies in different models. For example, EVs isolated from systemic lupus erythematosus patients enhanced the production of TNF-α and other proinflammatory cytokines via the TLR-related pathways ⁴⁵.

Another crucial immune response process is the production of nitric oxide (NO) and its mediated signaling transduction. Both NO-mediated signaling transduction and cGMP-mediated signaling were enriched after treatment with milk EVs. One is the inducible nitric oxide synthase (iNOS), which produces NO ⁴⁶. These results are consistent with previous studies on other cellular models, where EVs derived from hypoxic cardiomyocytes promoted NO production in endothelial cells ⁴⁷. Moreover, the release of EVs from senescent macrophages containing iNOS has been reported; bovine milk EVs containing miR-155-5p – an essential regulator of eNOS and NO – increased eNOS in endothelial cells. This suggests that EV cargo might also play an important role in modulating NO production ^48,49.

Further proteins such as Clusterin (CLU) and SAM and SH3 domain-containing 3 protein (SASH3) were annotated in several previously described immune-related processes. CLU, also known as apolipoprotein J, is a ubiquitously expressed glycoprotein and a known extracellular chaperone that has been shown to exert immunomodulatory and anti-inflammatory effects such as modulation of antimicrobial responses, facilitation of apoptotic cell clearance and suppression of kidney macrophage infiltration ^50,51. CLU can be found in both milk and milk EVs and is one of the proteins implied to modulate the immune response of the offspring ⁵². SASH3 is an adaptor protein involved in signal transduction ⁵³. These results suggest that EVs can modulate different aspects of innate and adaptive immunity, confirming their pleiotropic functions.

In the secretion and regulation of body fluids BP, proteins such as \(\:\beta\:\)-caseins and \(\:\kappa\:\)-casein (CSN2 and CSN3) were found. Caseins are the most abundant proteins in milk, and, besides many other functions ⁵⁴, they enhance EV uptake, altering the gene expression in blood cells ⁵⁵.

Overall, these results provide a molecular background to previously reported in vitro activity of EV on porcine PBMC ¹⁴. In vitro studies demonstrated that EVs induce changes in porcine monocyte chemotaxis, phagocytosis, and ROS production. These findings confirmed that BP involved in the same immune-related activities are enriched. Therefore, we can hypothesize that EVs can function as potential nanocarriers of immunomodulatory molecules that participate in immunity transmission from the mother to the offspring, helping modulate the newborn immune system.

Biological processes enriched by DP with the highest abundance in the control group

In contrast to what was observed in the milk EVs group, the 142 DP with a higher abundance in the control group were annotated mainly by very general BP, such as different metabolic processes, cellular organization, translation, and vesicle-mediated transport.

Other processes related to cell death and immune-related processes, such as regulation of anoikis, a subtype of apoptosis caused when cells lose their adhesive capability ⁵⁶, and interleukin-27-mediated signaling pathway. Interleukin-27 (IL-27) is a cytokine produced by monocytes, macrophages, and DC, with both pro- and anti-inflammatory and other immunoregulatory functions, and is also involved in cell proliferation, differentiation, and expression of cytokines ⁵⁷.

Altogether, these results highlight that after porcine milk EVs treatment, a functional switch from very general BP to others mostly related to immune response and EVs uptake processes occurred.

DP with greater changes in abundance in the PBMC incubated with milk EVs

To identify key DP that presented more significant changes in their raw abundances after porcine milk EVs treatment, their logFC was calculated. The protein with the highest amount after treatment with milk EVs was β-casein (CSN2), one of the most abundant proteins in milk. Besides nourishing the offspring by being a significant source of amino acids, caseins also have immunomodulatory effects, being broken down into immunomodulatory peptides ^58,59. Alpha-s1-casein (CSN1S1) and Alpha-s2-casein (CSN1S2) were also found but in lesser abundance than CSN2. After proteomics analyses, CSN2 and CSN1S1 were detected in bovine milk EVs ^43,60. Interestingly, CSN1S1 was shown to be expressed outside the mammary gland and to be expressed by immune cells such as monocytes and T cells ⁶¹. Moreover, this protein has been shown to exert immunomodulatory effects on monocytes, such as inducing the expression of IL-1β and the in vitro differentiation towards a macrophage-like phenotype ^61,62.

Finally, the butyrophilin subfamily 1 member A1 (BTN1A1), Na(+)-dependent phosphate cotransporter 2B protein (SLC34A2), and MFGE8 proteins also presented greater changes in their abundance in the PBMC-treated group. BTN1A1 is a member of the immunoglobulin superfamily first discovered in milk and is mainly associated with milk fat globules. Immunomodulatory roles of this protein have also been reported, primarily inhibitory effects on CD4 + T cell proliferation and T cell expression of cytokines associated with T cell activation ⁶³[96]. The SLC34A2 is a multi-pass membrane protein that has been involved in the activation of the complement alternative pathway (C3 and C4b) ^64,65, while MFGE8 function has been previously described ^31,33,35.

On the contrary, lower abundances in the fatty acid-binding protein 4 (FABP4) and galectin-3 (LGALS3) were found. FABP4 is a protein that plays a crucial role in fatty acid transportation and functions as a transmitter linking fatty acid metabolism to inflammation. LGALS3 is a carbohydrate-binding protein highly expressed in monocytes and macrophages and a potent regulator of cell migration and phagocytosis, among other immune and inflammation-related processes ^66,67.

In conclusion, the results of this study demonstrate for the first time that porcine milk EVs can modulate porcine PBMC proteome in vitro. The GO enrichment analysis revealed that the DP with higher abundance in the porcine milk EVs group mainly were related to innate immune-related processes. Our results also suggest that porcine milk EVs might exert pleiotropic immunomodulatory functions on PBMC by increasing the abundance of proteins with both immune-enhancing and dampening properties. Therefore, these results confirm the suppressive and enhancing effects of porcine milk EVs on porcine monocytes, observed in our previous in vitro study, where a decrease in the cells' phagocytosis and chemotaxis and an increase in their oxidative burst was detected. Moreover, detecting caseins and other milk proteins with known immunomodulatory properties exemplifies how EVs could fulfill their functions in intercellular communication by transferring their cargo to target cells. By providing a molecular background of porcine milk EVs’ immunomodulatory activity, we can better understand their potential role in the sow-to-piglet transmission of regulatory molecules and immunomodulation. Finally, additional molecular pathway enrichment, protein-protein interaction analyses, and integration of proteomics data with other OMIC technologies should be performed to have a holistic view of the impact of porcine milk EVs on porcine immunity.

Experimental design

The present study aims to determine the proteome of porcine peripheral blood mononuclear cells (PBMC) after co-incubation with purified EVs from sow milk.

Porcine PBMC were isolated from blood and co-incubated with porcine EVs purified from milk. The experiment was carried out in triplicate. Proteins were extracted from cells, and the proteome was determined by Nano-LC-MS/MS analysis.

Purification of porcine PBMC from blood

Porcine PBMC were isolated from peripheral blood through Ficoll density gradient centrifugation, as previously described for bovine blood, with some minor modifications ⁶⁸. Briefly, 100 mL of blood from seven 60–100 kg healthy pigs (Topigs Norsvin Italia S.r.l., Italy) was collected during routine slaughtering procedures in sterile flasks containing 0.2% of EDTA (Sigma-Aldrich, St. Louis, MO, USA) as an anticoagulant. Blood was then centrifuged at 1260 x g for 30 min at 18°C to obtain the buffy coat. The buffy coat was diluted 1:5 in cold sterile Dulbecco's PBS without Ca²⁺ and Mg²⁺ + 2 mM EDTA (Sigma-Aldrich), carefully layered onto Ficoll-Paque Plus (1.077g/mL) (GE Healthcare Bio-Sciences AB, Uppsala, Sweden), and centrifuged at 1700 x g (without brakes) for 30 min at 4°C to obtain the PBMC ring. PBMC were collected at the interface, washed with cold, sterile PBS without Ca²⁺ and Mg²⁺ + 2 mM EDTA, centrifuged at 500 x g for 7 min at 4°C and incubated with Red Blood Cell Lysis buffer (Roche Diagnostics GmbH, Mannheim, Germany) for 3 min at room temperature to remove the red blood cells. Washes with cold sterile PBS + 2 mM EDTA were performed to remove contaminant platelets. Finally, the PBMC were counted using an automatic cell counter (TC20TM, BioRad). Their viability was assessed with trypan blue exclusion and resuspended at the desired concentration in complete medium (RPMI 1640 Medium + 25 mM HEPES + L-Glutamine, supplemented with 1% of Non-essential Amino Acid Solution 100X and 1% Penicillin Streptomycin Solution 100X and 1% EVs -depleted Fetal Bovine Serum (FBS) (Sigma-Aldrich).

PBMC stimulation with porcine milk EVs

First, porcine milk EVs were purified from sows' milk and characterized using their concentration, size, morphology/structure, and presence of EVs marker protein, as previously reported ¹⁴. An aliquot of LPS-depleted porcine milk EVs (6.2 x 10¹⁰ EVs /mL) was thawed and used for each experiment. Briefly, a total of 15 x 10⁶ porcine PBMC (1.5 mL) were seeded in triplicates in Corning® tissue-culture treated culture 60 mm dishes (Corning Inc., Costar, Kennebunk, ME, USA) and incubated with 3 x 10⁹ porcine milk EVs (in a ratio of 200 EV/cell) for 22 h at 39°C in a humified atmosphere with 5% CO₂. A complete medium (1% EVs -depleted FBS) was added to each dish to reach a final volume of 3 mL.

The utilized ratio of EVs /cell was selected based on the immunomodulatory effects previously observed in vitro using a similar range of 10⁶–10⁸ EVs on rhesus macaques’ PBMC and T cells ⁶⁹ and in our previous study on porcine monocytes, where we did not observe toxic effects on porcine monocytes¹⁴.

Porcine PBMC collection and protein extraction

After incubation, 3mL of the cells in suspension (lymphocytes) were collected and centrifuged at 500 x g for 7 min at 4°C. The lymphocytes were washed twice with 500 µL sterile-PBS without Ca²⁺ and Mg²⁺ (room temperature) and centrifuged twice at 500 x g for 7 min at 4°C to remove the remaining medium and FBS. In the meantime, three washes with 2 mL of sterile-PBS without Ca²⁺ and Mg²⁺ (room temperature) were performed in the 60 mm dishes to wash the adhered monocytes and remove dead cells. When both the lymphocytes pellet and the adhered monocytes were washed, 500 µL of Igepal buffer (150 mM NaCl, 10 mM Tris-HCl pH 7.4, 1 mM EDTA and EGTA, 100 mM NaF, 4 mM Na₄P₂O₇·10 H₂O, 2 mM Na₃VO₄, 1% Triton X100, 0.5% IGEPAL CA-630 (Sigma-Aldrich), 1 pill for 50 mL of the total volume of Protease Inhibitor Cocktail (Roche)) was added to the lymphocytes pellet. The lymphocytes were resuspended and added directly to the 60 mm dishes containing the monocytes. The plates containing the cells and the Igepal buffer were incubated for 1h at 4°C with regular shaking to allow the lysis of the cells. After incubation, the cells were scraped using sterile Corning Cell scrapers (blade L 1.8 cm, handle L 25 cm; Corning Inc.), and the cell lysate was collected and sonicated for 10 min in an ultrasonic bath (Branson 2200, Danbury, CT, USA) to complete the cells' lysis and homogenization. Finally, the cell lysates were centrifuged for 10 min at 6000 x g at 4°C to remove the cell debris, and the supernatant containing the extracted proteins of all 3 technical replicates for each biological replicate was pooled in 1.5 mL tubes, aliquoted and stored at -80°C for further analyses.

Sample preparation for proteomic analysis

The total protein concentration was determined with the Pierce Bicinchoninic acid (BCA) protein assay kit (Thermo Fisher Scientific, Rockford, IL, USA), following the manufacturer's instructions. For peptide preparation, extracted proteins were digested and concentrated using the Filter Aided Sample Preparation (FASP) method, following the manufacturer's instructions with minor modifications. Briefly, 50 µg of protein lysate was loaded into Millipore 10 kDa MWCO filters, and 100 µl of Urea 8 M in 0.1 M Tris-HCl pH 8.5 were added for solubilization. The detergent and other contaminant components within the protein lysate were removed by repeated filtration by centrifugation. After discarding the flow-through, proteins were reduced with 100 µl DTT (10 mM) for 46 min and centrifuged at 14000 rpm for 10 min. Then, 200 µl of 25 mM iodoacetamide solution were added to the filters and incubated for 20 min at room temperature for protein alkylation. After performing several washes of the filters with Urea 8 M and 50 mM of ammonium bicarbonate, proteins were digested with 200 µl of 0.25 mg/mL trypsin (50:1 ratio of protein:enzyme) and mixed at 600 rpm in a thermomixer for 1 min. Filters were transferred to new collection tubes and incubated overnight in a wet chamber at 37°C. Finally, peptides were eluted by adding 200 µl of 50 mM of ammonium bicarbonate, and the filtrate was lyophilized in a SpeedVac and then resuspended in 100 µl of 1% formic acid.

Nano-LC-MS/MS analysis

For each sample, 50µg of proteins were used according to the FASP preparation. The final volume was adjusted to 300 µL with a recovery solution (H₂O/ACN/TFA – 94.95/5/0.05). After passing through the ultrasonic bath (10 min), the supernatant was transferred to an HPLC vial before LC-MS/MS analysis. Peptide mixtures were analyzed by nano-LC-MS/MS (ThermoFisher Scientific) using an Ultimate 3000 system coupled to a QExactive HF-X mass spectrometer (MS) with a nanoelectrospray ion source. Five µL of hydrolysate was first preconcentrated and desalted at a flow rate of 30 µl/mn on a C18 pre-column 5 cm length x 100 µm (Acclaim PepMap 100 C18, 5µm, 100A nanoViper) equilibrated with Trifluoroacetic Acid 0.05% in water. After 6 min, the concentration column was switched online with a nanodebit analytical C18 column (Acclaim PepMap 100 − 75 µm inner diameter × 25 cm length; C18–3 µm -100Å - SN 20106770) operating at 400 nL/min equilibrated with 96% solvent A (99.9% H2O, 0.1% formic acid). The peptides were then separated according to their hydrophobicity thanks to a gradient of solvent B (99.9% acetonitrile, 0.1% formic acid) of 4 to 25% in 60 minutes. For MS analysis, eluted peptides were electrosprayed in positive-ion mode at 1.6 kV through a Nano electrospray ion source heated to 250°C. The mass spectrometer operated in data-dependent mode: the parent ion is selected in the orbitrap cell (FTMS) at a resolution of 60,000, and 18 MS/MS succeeds each MS analysis with analysis of the MS/MS fragments at a resolution of 15,000).

Processing of raw mass spectrometry data

At the end of the LC-MS/MS analysis, for raw data processing, an MS/MS ion search was carried out with Mascot v2.5.1 (http://www.matrixscience.com) against the porcine database (i.e., ref_sus_scrofa 20210114-49,792 sequences). The following parameters were used during the request: precursor mass tolerance of 10 ppm and fragment mass tolerance of 0.02 Da, a maximum of two missed cleavage sites of trypsin, carbamidomethylation (C), oxidation (M) and deamidation (NQ) set as variable modifications. Protein identification was validated when at least two peptides originating from one protein showed statistically significant identity above Mascot scores with a False Discovery Rate of 1%. Ions score is -10 log(P), where P is the probability that an observed match is a random event. For the porcine proteome, the Mascot score was 32 with a False Discovery Rate (FDR) of 1%. The adjusted p-value was 0.02747. Finally, LC-Progenesis QI software (version 4.2, Nonlinear Dynamics, Newcastle upon Tyne, UK) was used for label-free protein quantification analysis with the same identification parameters described above with the phenotypic data among all matrices. All unique validated peptides of an identified protein were included, and the total cumulative abundance was calculated by summing the abundances of all peptides allocated to the respective protein. LC-Progenesis analysis yielded 1584 unique quantifiable proteins, with at least two and two unique peptides.

Statistical analyses

To identify the differentially abundant proteins, a univariate statistical approach was performed on all 1584 quantified proteins, using an R package for proteomic analysis (available on GitHub with the DOI https://doi.org/10.5281/zenodo.2539329) as previously described ⁷⁰[25]. Briefly, data normality distribution was assessed by the Shapiro-Wilk-Test. Then, either a paired Student's t-test for normally distributed data or a paired Wilcoxon test for not normally distributed data was applied to determine the p-value. Finally, the obtained p-values were corrected using different adjustment methods (e.g., Benjamini & Hochberg or FDR, Hochberg, and Bonferroni). For all of these analyses, R version 4.2.2 was used.

An alternative supervised multilevel sparse variant partial least square discriminant analysis (sPLS-DA) was applied as no differentially abundant proteins were detected using the -test or Wilcoxon tests. The multilevel sPLS-DA enables the selection of the most predictive or discriminant proteins in the data of the two components (PC1 and PC2) to classify or cluster the samples between the treatment groups ²⁰. The multivariate analysis used the mixOmics package in R (http://mixomics.org).

Bioinformatic analysis of discriminant proteins (DP) selected by sPLS-DA

First, before performing the bioinformatic and functional annotation analyses, the accession numbers from all 1584 quantified proteins were converted into Gene ID using the UniProt retrieve/ID mapping online tool. The Gene ID of human orthologs of porcine proteins was assigned for undefined proteins. Second, only for the selected DP a gene ontology (GO) enrichment analysis focused on the Biological Processes (BP) was performed using ProteINSIDE online tool version 2.0 (available at https://umrh-bioinfo.clermont.inrae.fr/ProteINSIDE_2/index.php?page=upload.php), as previously described [27], and using Sus scrofa as reference specie. Only significant (FDR < 0.05) GO BP terms were considered enriched and were used for further interpretation and figure creation. The enriched GO BP terms were summarized, and their enrichments were expressed as -log10 (FDR) for visualization on horizontal bar graphs plotted using GraphPad Prism 9.1.2 for Mac OS X, GraphPad Software (San Diego, California, USA). Finally, the average log fold-change (logFC) of the raw abundances of all the DP identified with sPLS-DA from all seven 7 biological replicates was calculated and plotted using R version 4.2.2.

APOE

apolipoprotein E

Biological processes

BTN1A1

butyrophilin subfamily 1 member A1

CSN1S1

Alpha-s1-casein

CSN1S2

Alpha-s2-casein

CNS1

β-caseins

CSN2

κ-casein

CTSH

Cathepsin H

eNOS

endothelial nitric oxide synthase

Extracellular Vescicles

FDR

False Discovery Rate

Gene Ontology

Discriminant Protein

ERK1/2

extracellular signal-regulated kinase 1/2FABP4:fatty acid-binding protein 4

iNOS

inducible nitric oxide synthase

LGALS3

galectin-3

MFGE8

lactadherin

nano-LC-MS/MS

Nanoscale liquid chromatography coupled to tandem mass spectrometry

Natural Killer

Nitric Oxide

PBMC

Peripheral Blood Mononuclear Cells

ROS

Reactive Oxygen Species

SASH3

SH3 domain-containing 3 protein

SLC34A2

Na(+)-dependent phosphate cotransporter 2B protein

sPLS-DA

partial least square discriminant analysis

TLR

Toll-Like Receptor

Ethics statement

The procedures for the blood collection were carried out during routine slaughtering procedures. The milk collection from sows was carried out in the frame of a study approved by the Ethical Committee of the University of Milan (OPBA 67/2018) and the Italian Ministry of Health (authorization n. 168/2019 PR)

Consent for publication

Not applicable.

Competing interests

None of the authors of this paper has a financial or personal relationship with other people or organizations that could inappropriately influence or bias the paper's content.

Availability of data and materials

All data generated or analyzed during this study are included in this published article [and its supplementary information files].

Acknowledgments

The authors acknowledge A. Delavaud (INRAE, Herbivore Research Unit) for his technical assistance in protein extraction, quantification, and concentration for mass spectrometry analyses, and also Arnaud Cougoul, Jeremy Tournayre and Céline Boby (INRAE, Herbivore Research Unit) for their assistance in the statistical and bioinformatic analyses, respectively.

Authors’ contribution

G. Ávila: Writing – original draft, Software, Methodology, Investigation, Formal analysis, Conceptualization. F. Ceciliani: Writing – review & editing, Writing – original draft, Validation, Supervision, Project administration, Funding acquisition, Conceptualization. D. Viala: Writing – original draft, Software, Resources, Methodology, Formal analysis, Data curation. S. Dejean: Writing – review & editing, Software, Resources, Formal analysis, Data curation. A. Agazzi: Resources, Methodology. C. Lecchi: Writing – review & editing, Validation. M. Bonnet: Writing – review & editing,

Funding

This study was supported by the European Union's Horizon 2020 research and innovation program H2020-MSCA- ITN-2017- EJD: Marie Skłodowska-Curie Innovative Training Networks (European Joint Doctorate) [Grant agreement nº: 765423, 2017] – MANNA.

Kalluri, R. & LeBleu, V. S. The biology<strong>,</strong> function<strong>,</strong> and biomedical applications of exosomes. Science (80-. ). 367, eaau6977 (2020).
Becker, A. et al. Extracellular Vesicles in Cancer: Cell-to-Cell Mediators of Metastasis. Cancer Cell 30, 836–848 (2016).
Wen, C. et al. Biological roles and potential applications of immune cell-derived extracellular vesicles. J. Extracell. Vesicles 6, 1–19 (2017).
Raposo, G. & Stoorvogel, W. Extracellular vesicles: Exosomes, microvesicles, and friends. J. Cell Biol. 200, 373–383 (2013).
Chow, A. et al. Macrophage immunomodulation by breast cancer-derived exosomes requires Toll-like receptor 2-mediated activation of NF-κ B. Sci. Rep. 4, (2014).
Raposo, G. et al. B lymphocytes secrete antigen-presenting vesicles. J. Exp. Med. 183, 1161–1172 (1996).
Chaput, N. & Théry, C. Exosomes: Immune properties and potential clinical implementations. Semin. Immunopathol. 33, 419–440 (2011).
Dalvi, P., Sun, B., Tang, N. & Pulliam, L. Immune activated monocyte exosomes alter microRNAs in brain endothelial cells and initiate an inflammatory response through the TLR4/MyD88 pathway. Sci. Rep. 7, 1–12 (2017).
Chen, W. et al. Immunomodulatory effects of mesenchymal stromal cells-derived exosome. Immunol. Res. 64, 831–840 (2016).
Admyre, C. et al. Exosomes with Immune Modulatory Features Are Present in Human Breast Milk. J. Immunol. 179, 1969–1978 (2007).
Lässer, C. et al. Human saliva, plasma and breast milk exosomes contain RNA: Uptake by macrophages. J. Transl. Med. 9, 9 (2011).
Izumi, H. et al. Bovine milk exosomes contain microRNA and mRNA and are taken up by human macrophages. J. Dairy Sci. 98, 2920–2933 (2015).
Manca, S. et al. Milk exosomes are bioavailable and distinct microRNA cargos have unique tissue distribution patterns. Sci. Rep. 8, 11321 (2018).
Ávila Morales, G. et al. Porcine milk exosomes modulate the immune functions of CD14+ monocytes in vitro. Sci. Rep. 13, 21447 (2023).
Pardanani, A., Wieben, E. D., Spelsberg, T. C. & Tefferi, A. Primer on medical genomics part IV: expression proteomics. in Mayo Clinic Proceedings 77, 1185–1196 (Elsevier, 2002).
Sun, J., Shi, Z., Guo, H. & Tu, C. Changes in the porcine peripheral blood mononuclear cell proteome induced by infection with highly virulent classical swine fever virus. J. Gen. Virol 91, 2254–2262
Valent, D. et al. Effects on pig immunophysiology, PBMC proteome and brain neurotransmitters caused by group mixing stress and human-animal relationship. PLoS One 12, 0176928– 0176928
Chae, J.-I. et al. Quantitative proteomic analysis of pregnancy-related proteins from peripheral blood mononuclear cells during pregnancy in pigs. Anim. Reprod. Sci 134, 164–176
Ramirez-Boo, M. et al. Analysis of porcine peripheral blood mononuclear cells proteome by 2-DE and MS: Analytical and biological variability in the protein expression level and protein identification. Proteomics 6, 215– 225
Lê Cao, K.-A., Boitard, S. & Besse, P. Sparse PLS discriminant analysis: biologically relevant feature selection and graphical displays for multiclass problems. BMC Bioinformatics 12, 253 (2011).
May, R. C. & Machesky, L. M. Phagocytosis and the actin cytoskeleton. J. Cell Sci. 114, 1061–1077 (2001).
Affolter, M. & Weijer, C. J. Signaling to Cytoskeletal Dynamics during Chemotaxis. Dev. Cell 9, 19–34 (2005).
Roy, N. H. & Burkhardt, J. K. The Actin Cytoskeleton: A Mechanical Intermediate for Signal Integration at the Immunological Synapse . Frontiers in Cell and Developmental Biology 6, (2018).
Brown, E., Weering, J., Sharp, T., Mantell, J. & Verkade, P. Chapter 10 - Capturing Endocytic Segregation Events with HPF-CLEM. Light Electron Microsc., Acad. Press 175–201 doi:10.1016/B978-0-12-416026-2.00010-8.
Knaap, J. A. & Verrijzer, C. P. Undercover: gene control by metabolites and metabolic enzymes. Genes Dev 30, 2345–2369
Uribe-Querol, E. & Rosales, C. Phagocytosis: Our Current Understanding of a Universal Biological Process , Front. Immunol 11,
Kalluri, R. The biology and function of exosomes in cancer. J. Clin. Invest 126, 1208–1215
L., S. R. & Maria, F. CD36, a Scavenger Receptor Involved in Immunity, Metabolism, Angiogenesis, and Behavior, Sci. Signal 2, 3– 3
Baranova, I. N. et al. Role of human CD36 in bacterial recognition, phagocytosis, and pathogen-induced JNK-mediated signaling. J. Immunol 181, 7147–7156
Park, Y. M., Febbraio, M. & Silverstein, R. L. CD36 modulates migration of mouse and human macrophages in response to oxidized LDL and may contribute to macrophage trapping in the arterial intima. J. Clin. Invest 119, 136–145
Sugano, G. et al. Milk fat globule—epidermal growth factor—factor VIII (MFGE8)/lactadherin promotes bladder tumor development. Oncogene 30, 642–653
Dasgupta, S. K. & Thiagarajan, P. The Role of Lactadherin in the Phagocytosis of Phosphatidylserine-Expressing Sickle Red Blood Cell by Macrophages. Blood 106, 3773
Zhou, Y.-J. et al. The role of the lactadherin in promoting intestinal DCs development in vivo and vitro, Clin. Dev. Immunol 357541 doi:10.1155/2010/357541.
Magdanz, V., Boryshpolets, S., Ridzewski, C., Eckel, B. & Reinhardt, K. The motility-based swim-up technique separates bull sperm based on differences in metabolic rates and tail length. PLoS One 14, (2019).
Reinhardt, T. A., Lippolis, J. D., Nonnecke, B. J. & Sacco, R. E. Bovine milk exosome proteome. J. Proteomics 75, 1486–1492 (2012).
Murphy, D. E. et al. Extracellular vesicle-based therapeutics: natural versus engineered targeting and trafficking, Exp. Mol. Med 51, 1–12
Wortzel, I. & Seger, R. The ERK Cascade: Distinct Functions within Various Subcellular Organelles. Genes Cancer 2, 195–209
Svensson, K. J. et al. Exosome uptake depends on ERK1/2-heat shock protein 27 signaling and lipid Raft-mediated endocytosis negatively regulated by caveolin-1. J. Biol. Chem 288, 17713–17724
Ma, J. et al. Mesenchymal stem cell-derived exosomal miR-21a-5p promotes M2 macrophage polarization and reduces macrophage infiltration to attenuate atherosclerosis. Acta Biochim. Biophys. Sin. (Shanghai 53, 1227–1236
Getz, G. S. & Reardon, C. A. Apoproteins E, A-I, and SAA in Macrophage Pathobiology Related to Atherogenesis. Front. Pharmacol 10,
Baitsch, D. et al. No Title. Apolipoprotein E Induces Anti-inflamm. Phenotype Macrophages, Arter. Thromb. Vasc. Biol 31, 1160–1168
Zheng, P. et al. Tumor-associated macrophages-derived exosomes promote the migration of gastric cancer cells by transfer of functional Apolipoprotein E. Cell Death Dis 9, 434
Ferreira, R. F. et al. Comparative proteome profiling in exosomes derived from porcine colostrum versus mature milk reveals distinct functional proteomes. J. Proteomics 104338 (2021). doi:https://doi.org/10.1016/j.jprot.2021.104338
Wang, H., Du, S., Cai, J., Wang, J. & Shen, X. Apolipoprotein E2 Promotes the Migration and Invasion of Pancreatic Cancer Cells via Activation of the ERK1/2 Signaling Pathway, Cancer Manag. Res 12, 13161–13171
Lee, J. Y., Park, J. K., Lee, E. Y., Lee, E. B. & Song, Y. W. Circulating exosomes from patients with systemic lupus erythematosus induce a proinflammatory immune response, Arthritis Res. Ther 18, 264
Abdul-Cader, M. S., Amarasinghe, A. & Abdul-Careem, M. F. Activation of toll-like receptor signaling pathways leading to nitric oxide-mediated antiviral responses. Arch. Virol 161, 2075–2086
Li, H. et al. Coronary Serum Exosomes Derived from Patients with Myocardial Ischemia Regulate Angiogenesis through the miR-939-mediated Nitric Oxide Signaling Pathway. Theranostics 8,
Hattori, H. et al. Senescent RAW264.7 cells exhibit increased production of nitric oxide and release inducible nitric oxide synthase in exosomes. Mol Med Rep 24, 681
Tan, X.-H. et al. Skimmed Bovine Milk-Derived Extracellular Vesicles Isolated via ‘Salting-Out’: Characterizations and Potential Functions as Nanocarriers. Front. Nutr 8,
Weng, X. et al. Clusterin regulates macrophage expansion, polarization and phagocytic activity in response to inflammation in the kidneys, Immunol. Cell Biol 99, 274–287
Cunin, P. et al. Clusterin facilitates apoptotic cell clearance and prevents apoptotic cell-induced autoimmune responses. Cell Death Dis 7, 2215– 2215
Cintio, M. et al. MicroRNA Milk Exosomes: From Cellular Regulator to Genomic Marker. Anim. an Open Access J. from MDPI 10, 1126
Delmonte, O. M. et al. P.M. Blood 138, 1019–1033
Wang, X. et al. Proteomic analysis and cross species comparison of casein fractions from the milk of dairy animals. Sci. Rep. 7, (2017).
Aminzadeh, M. A. et al. Casein-enhanced uptake and disease-modifying bioactivity of ingested extracellular vesicles. J. Extracell. Vesicles 10, 12045
Malagobadan, S. & Nagoor, N. H. Anoikis. (Academic Press). doi:10.1016/B978-0-12-801238-3.65021-3.
Aparicio-Siegmund, S. & Garbers, C. The biology of interleukin-27 reveals unique pro- and anti-inflammatory functions in immunity. Cytokine Growth Factor Rev 26, 579–586
Wheeler, T. T., Hodgkinson, A. J., Prosser, C. G. & Davis, S. R. Immune Components of Colostrum and Milk—A Historical Perspective. J. Mammary Gland Biol. Neoplasia 12, 237–247
Sadler, M. J. & Smith, N. Beta-casein proteins and infant growth and development. Infant J 9, 173–176
Samuel, M. et al. Bovine milk-derived exosomes from colostrum are enriched with proteins implicated in immune response and growth. Sci. Rep. 7, 5933 (2017).
Vordenbäumen, S. et al. Casein α s1 is expressed by human monocytes and upregulates the production of GM-CSF via p38 MAPK. J. Immunol 186, 592–601
Vordenbäumen, S. et al. Human casein alpha s1 (CSN1S1) skews in vitro differentiation of monocytes towards macrophages. BMC Immunol 14, 46
Arnett, H. A. & Viney, J. L. Immune modulation by butyrophilins. Nat. Rev. Immunol 14, 559–569
Wang, Y. et al. The effects and mechanisms of SLC34A2 in tumorigenesis and progression of human non-small cell lung cancer. J. Biomed. Sci 22, 52
Yang, W. et al. Elevated expression of SLC34A2 inhibits the viability and invasion of A549 cells, Mol. Med. Rep 10, 1205–1214
Brinchmann, M. F., Patel, D. M. & Iversen, M. H. The Role of Galectins as Modulators of Metabolism and Inflammation. Mediators Inflamm. 2018, 9186940 (2018).
Lu, Y. et al. Modified citrus pectin inhibits galectin-3 function to reduce atherosclerotic lesions in apoE-deficient mice. Mol Med Rep 16, 647–653 (2017).
Ceciliani, F. et al. Methods in isolation and characterization of bovine monocytes and macrophages. Methods (2020). doi:10.1016/j.ymeth.2020.06.017
Hong, X., Schouest, B. & Xu, H. Effects of exosome on the activation of CD4+ T cells in rhesus macaques: a potential application for HIV latency reactivation. Sci. Rep. 7, 15611 (2017).
Bazile, J., Picard, B., Chambon, C., Valais, A. & Bonnet, M. Pathways and biomarkers of marbling and carcass fat deposition in bovine revealed by a combination of gel-based and gel-free proteomic analyses. Meat Sci. 156, 146–155 (2019).

No competing interests reported.

Download PDF

Editor invited by journal
23 Aug, 2024
Submission checks completed at journal
22 Aug, 2024
First submitted to journal
21 Aug, 2024

You are reading this latest preprint version

Porcine milk small extracellular vesicles modulate peripheral blood mononuclear cell proteome in vitro

Status:

Version 1

Abstract

Figures

Introduction

Results

Average log fold-change (logFC) of the abundances of the DP identified with sPLS-DA

Discussion

Biological processes enriched by DP with the highest abundance in the control group

DP with greater changes in abundance in the PBMC incubated with milk EVs

Materials and Methods

Experimental design

Purification of porcine PBMC from blood

PBMC stimulation with porcine milk EVs

Porcine PBMC collection and protein extraction

Sample preparation for proteomic analysis

Nano-LC-MS/MS analysis

Processing of raw mass spectrometry data

Statistical analyses

Bioinformatic analysis of discriminant proteins (DP) selected by sPLS-DA

Abbreviations

Declarations

References

Additional Declarations

Supplementary Files

Status:

Version 1